To compare pain relief medication Buprenorphine as a skin patch that delivers 5 micrograms per hour and one time dose of 75 micrograms of Buprenorphine injected directly into spinal area to evaluate postoperative pain for patients undergoing lower abdominal surgeries

Comparative study of Transdermal Patch of BUPRENORPHINE 5mg(5mcg/hour) and Intrathecal BUPRENORPHINE 75 mcg for postoperative pain control in patients undergoing below Umbilicus surgery under Regional Anaesthesia - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/074928

Enrollment

Registered

2024-10-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

Intervention1: LEVOBUPIVACAINE WITH TRANSDERMAL PATCH BUPRENORPHINE: Intrathecal Levobupivacaine 0.5% heavy with transdermal patch buprenorphine for postoperative pain control in patients undergoing b

Eligibility

Inclusion criteria

Inclusion criteria: 1. American society of anaesthesiologists (ASA) grade I,II 2. Age group between 18-60 years of both sexes 3. Scheduled for elective below umbilicus surgery under regional anaesthesia

Exclusion criteria

Exclusion criteria: 1.Patient refusal 2.History of skin allergy or allergy to study drug 3.American Society of Anesthesiologists (ASA) grade III and IV 4.Patients who had Pre-existing pain in non-surgical site 5.Post spinal surgeries, Spinal Deformities, Skin sepsis in lumbar region, Patients with pre-existing neurological disorders 6.BMI more than 35,Height less than 140 cms 7.Pregnant patients 8. Coagulopathy

Design outcomes

Primary

Measure	Time frame
To compare the duration of analgesiaTimepoint: First 24 hours	—

Secondary

Measure	Time frame
To compare the hemodynamic parameters between both groups and side effects if anyTimepoint: First 24 hours	—

Countries

India

Contacts

Public ContactS VAISHNAVI

Chettinad Hospital And Research Institute

ashokk_dr@yahoo.com9840498420

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026